Cisen Pharmaceutical Co., Ltd. (SHSE:603367) announced that it scraps unit spin-off plan due to changes in capital market environment.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.23 CNY | -1.16% | -2.35% | +10.86% |
Apr. 23 | Cisen Pharmaceutical Names Chief Financial Officer | MT |
Apr. 22 | Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+10.86% | 1.03B | |
+21.26% | 44.12B | |
+20.93% | 22.61B | |
+17.81% | 15.11B | |
+15.90% | 13.61B | |
+55.56% | 13.34B | |
-9.60% | 6.94B | |
-0.05% | 6.79B | |
+14.03% | 5.75B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 603367 Stock
- News Cisen Pharmaceutical Co., Ltd.
- Cisen Pharmaceutical Scraps Unit Spin-Off Plan